Millie
your market intelligence analyst
Search Results
119 results
Your search is now limited to «Company News in Infectious Diseases» expert search.
FiercePharmaManufacturing 12/05/2019 14:37
RELATED: Merck's Ervebo, the world's first Ebola shot, wins inaugural approval in EU UNICEF, Gavi’s partner and purchasing agency, will determine pricing of the vaccines it buys.
More from FiercePharmaManufacturing:
NASDAQ 11/28/2019 08:44
Merck is collaborating with several companies including Amgen AMGN, Incyte, Glaxo and Pfizer PFE separately for the evaluation of Keytruda in combination with other regimens.
More from NASDAQ:
ENDPOINTS 11/26/2019 10:51
In 2018, Shionogi rolled out Xofluza in Japan as a one-pill kill for influenza, with Roche following suit in the US.
More from ENDPOINTS:
Updated Date: Fri, 15 Nov 2019 00:00:00 EST.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
PharmTech.com 11/14/2019 09:00
According to Takeda, Clinical Phase 1 and 2 data in children and adolescents showed that TAK-003 induced immune responses against all four dengue serotypes, in both seropositive and seronegative participants, and the vaccine was found to be ...
More from PharmTech.com:
Healio News 11/12/2019 15:46
Tedros Adhanom Ghebreyesus One day after winning conditional approval in Europe, Merck’s Ebola vaccine received prequalification status from WHO, giving it the agency’s stamp of approval as a safe and effective prevention tool against the deadly virus.
More from Healio News:
PMLiVE 11/12/2019 07:34
The approval comes shortly after Johnson & Johnson filed its Ebola vaccine candidate (Ad26.ZEBOV, MVA-BN-Filo) with the EMA, setting up a possible approval next year, and ahead of a potential approval of Ervebo in the US due next March.
More from PMLiVE:
Business Wire 11/11/2019 15:00
Merck’s Commitment to Infectious Diseases For more than 100 years, Merck has contributed to the discovery and development of novel medicines and vaccines to combat infectious diseases.
More from Business Wire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications